Culley Brian M (CIK 1310683) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-12). Recent activity: Buy LCTX (15,000 shares), Buy LCTX (31,250 shares), Sell LCTX (12,869 shares), Buy LCTX (8,925 shares), Sell LCTX (334 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-12 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Buy | 15,000 | $24,450 |
| 2026-02-13 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Buy | 31,250 | $0 |
| 2026-02-13 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Sell | 12,869 | $23,164 |
| 2025-12-19 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Buy | 8,925 | $0 |
| 2025-12-19 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Sell | 334 | $561 |
| 2025-02-12 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Buy | 31,249 | $0 |
| 2025-02-12 | Lineage Cell Therapeutics, Inc. (LCTX) | President and CEO | Sell | 12,547 | $8,156 |
Source: SEC Form 4 filings · as of 2026-03-12